Skip to Content
Merck

3951

Periodic Acid Solution

1 g/dL in deionized water

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

NACRES:
NA.47
PubChem Substance ID:
24864643
UNSPSC Code:
12352106
MDL number:
MFCD00011344

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

form

solution

Quality Level

500

shelf life

expiry date on label

reaction suitability

reagent type: oxidant

IVD

for in vitro diagnostic use

concentration

1 g/dL in deionized water

pH

1.77

application(s)

hematology
histology

shipped in

wet ice

storage temp.

2-8°C

SMILES string

OI(O)(O)(O)(O)=O

InChI

1S/H5IO6/c2-1(3,4,5,6)7/h(H5,2,3,4,5,6,7)

InChI key

TWLXDPFBEPBAQB-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Related Categories

Application

For use in procedure no. 395 for Periodic Acid-Schiff (PAS) and Silver Stain Procedure No. HT100.

pictograms

Corrosion
GHS05

signalword

Danger

hcodes

H314,H412

Hazard Classifications

Aquatic Chronic 3 - Eye Dam. 1 - Skin Corr. 1

Storage Class

8B - Non-combustible corrosive hazardous materials

wgk

WGK 2

ppe

Faceshields, Gloves, Goggles, type ABEK (EN14387) respirator filter

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
0000484327
0000484343
0000484343
0000484327
0000361262

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Sonja Frimmel et al.
Journal of ophthalmic & vision research, 12(2), 175-182 (2017-05-26)
Diabetic retinopathy is a leading cause of vision loss. There is a great need for early diagnosis prior to the occurrence of irreversible structural damages. Expression of endothelial adhesion molecules is observed before the onset of diabetic vascular damage; however
Allison M Bradbury et al.
Human gene therapy, 29(7), 785-801 (2018-01-11)
Globoid cell leukodystrophy (GLD), or Krabbe disease, is an inherited, neurologic disorder that results from deficiency of a lysosomal enzyme, galactosylceramidase. Most commonly, deficits of galactosylceramidase result in widespread central and peripheral nervous system demyelination and death in affected infants
Allison M Bradbury et al.
Journal of neuroscience research, 94(11), 1007-1017 (2016-09-18)
Globoid cell leukodystrophy (GLD), or Krabbe's disease, is a debilitating and always fatal pediatric neurodegenerative disease caused by a mutation in the gene encoding the hydrolytic enzyme galactosylceramidase (GALC). In the absence of GALC, progressive loss of myelin and accumulation
Robert W Morton et al.
The Journal of physiology, 597(17), 4601-4613 (2019-07-12)
Performing resistance exercise with heavier loads is often proposed to be necessary for the recruitment of larger motor units and activation of type II muscle fibres, leading to type II fibre hypertrophy. Indirect measures [surface electromyography (EMG)] have been used
Daniela Rovito et al.
Nucleic acids research, 49(8), 4472-4492 (2021-04-10)
Skeletal muscle is a dynamic tissue the size of which can be remodeled through the concerted actions of various cues. Here, we investigated the skeletal muscle transcriptional program and identified key tissue-specific regulatory genetic elements. Our results show that Myod1
View All Related Papers

Global Trade Item Number

SKUGTIN
27130-10G04061826143759
3951-100ML04061831982961

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service